Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for...
Reexamination Certificate
2007-11-20
2007-11-20
Saidha, Tekchand (Department: 1652)
Chemistry: molecular biology and microbiology
Enzyme , proenzyme; compositions thereof; process for...
C435S252300, C435S320100, C536S023200
Reexamination Certificate
active
10433238
ABSTRACT:
The present invention relates to elongase genes, their polypeptides and their control regions, and the use of such genes, polypeptides and control regions in determining compositions for use in the treatment of disease. The identified compositions regulate the expression of the elongase genes or modulate the activity of their protein products. The nucleotide and amino acid sequences are taught for ELG4, ELG6 and ELG7. The control sequences and function are taught for ELG1, ELG2, ELG3, ELG4, ELG5, ELG6 and ELG7.
REFERENCES:
patent: WO 00/12720 (2000-03-01), None
patent: WO 00/55333 (2000-09-01), None
patent: WO 00/70945 (2000-11-01), None
patent: WO 01/04636 (2001-01-01), None
patent: WO 01/87921 (2001-11-01), None
Sequence search alignment between Accession No. AW812215 and Applicants' SEQ ID No. 4 (the elected sequence).
Beaudoin, F., et al., “Heterologous Reconstitution in Yeast of the Polyunsaturated Fatty Acid Biosynthetic Pathway,” Proc. Natl. Acad. Sci. U.S.A., vol. 97, No. 12, pp. 6421-6426 (2000).
Cinti, D., et al., “The Fatty Acid Chain Elongation System of Mammalian Endoplasmic Reticulum,” Prog. Lipid Res., vol. 31, No. 1, pp. 1-51 (1992).
Evenson, et al., “Fatty Acid-Elongating Activity in Rapidly Expanding Leek Epidermis,” Plant Physiology, vol. 109, pp. 707-716 (1995).
Leonard, A., et al., “Cloning of a Human cDNA Encoding a Novel Enzyme Involved in the Elongation of Long-Chain Polyunsaturated Fatty Acids,” Biochem. J., vol. 350, pp. 765-770 (2000).
Marcelo, C., et al., “Fatty Acid Metabolism Studies of Human Epidermal Cell Cultures,” J. Lipid Res., vol. 34, pp. 2077-2090 (1993).
Oh, C., et al., “ELO2 and ELO3, Homologues of the Saccharomyces cerevisiae ELO1 Gene, Function in Fatty Acid Elongation and Are Required for Sphingolipid Formation,” J. Biol. Chem., vol. 272, No. 28, pp. 17376-17384 (1997).
Tvrdik, P., et al., “Role of a New Mammalian Gene Family in the Biosynthesis of Very Long Chain Fatty Acids and Sphingolipids,” J. Cell Biol., vol. 149, No. 3, pp. 707-717 (2000).
Parker-Barnes, J., et al., “Identification and Characterization of an Enzyme Involved in the Elongation of n-6 and n-3 Polyunsaturated Fatty Acids,” Proc. Natl. Acad. Sci. U.S.A., vol. 97, No. 15, pp. 8284-8289 (2000).
Toke, D., et al., “Isolation and Characterization of a Gene Affecting Fatty Acid Elongation in Saccharomyces cerevisiae,” J. Biol. Chem., vol. 271, No. 31, pp. 18413-18422 (1996).
P. Barrett, et al., “Effects of Pebulate and Pebulate Sulphoxide On Very Long Chain Fatty Acid Biosynthesis,” Phytochemicstry, vol. 48, No. 3, pp. 441-446 (1998).
R. Chapkin, et al., “Utilization of Gammalinolenic Acid By Mouse Peritoneal Macrophages, ” Biochimica et Biophysica Acta, 1085:365-370 (1991).
L. Chuang, et al., “Inhibitory Effect of Conjugated Linoleic Acid on Linoleic Acid Elongation in Transformed Yeast with Human Elongase,” 36:1099-1103 (2001).
D. Cinti, et al., “The Fatty Acid Chain Elongation System of Mammalian Endoplasmic Reticulum,” Prog. Lipid Res., vol. 31:1-51 (1992).
M. Cotter, et al., “The Aetiopathogenesis of Diabetic Neuropathy: Metabolic Theories,” Diabetic Neuropathy, pp. 97-119.
K. Dines, et al., “Contrasting Effects of Treatment with ω-3 and ω-6 Essential Fatty Acids On Peripheral Nerve Function and Capillarization in Streptozotocin-Diabetic Ratsn,” Diabetologia, 36:1132-1138 (1993).
A. Goszcz, et al. “Treatment of Peripheral Vascular Disease With Misoprostol (Cytotec®): A Pilot Study,” Methods Find Esp. Clin. Pharmacol., 20(5): 439-445 (1998).
D. James, et al., “Directed Tagging of the Arabidopsis Fatty Acid Elongatinl (FAEI) Gene with the Maize Transposon Activator,” The Plant Cell, vol. 7, 309-319 (Mar. 1995).
A. Kells, et al., “RT-PCR Of Fatty Acid Elongases,” 20 S Biochemical Society Transactions, 25 (1997).
A. Leonard, et al., “Cloning of a Human cDNA Encoding a Novel Enzyme Involved in the Elongation of Long-Chain Polyunsaturated Fatty Acids,” Biochemical, J., 350:765-770 (2000).
C. Oh, et al., “ELO2 and ELO3, Homologues of the Saccharomyces Cerevisiae EL01 Gene, Function in Fatty Acid Elongation and Are Required for Sphingolipid Formation,” The Journal of Biological Chemistrty, vol. 272, No. 28, Jul. 11, 1997, pp. 17376-17384.
R. Riemersma, et al., “Linoleic Acid Content in Adipose Tissue and Coronary Heart Disease,” British Medical Journal (Clin. Res. Ed.), vol. 292, May 31, 1986, p. 1423-1427.
P. Singer, et al., “Defective Desaturation and Elongation of N-6 and N-3 Fatty Acids in Hypertensive Patients,” Prostaglandins Leukotrienes and Medicine, 15:159-165 (1984).
S. Suneja, et al., “Enzyme Site-Specific Changes in Hepatic Microsomal Fatty Acid Chain Elongation in Streptozotocin-Induced Diabetic Rats,” Biochemica et Biophysica Acta, 1042:81-85 (1990).
D. Toke, et al., “Isolation and Characterization of a Gene Affecting Fatty Acid Elongation in Saccharomyces Cerevisiae,” The Journal of Biological Chemistry, vol. 271, No. 31, Aug. 2, 1996, pp. 18413-18422.
P. Tvrdik, et al., “Role of a New Mammalian Gene Family in the Biosynthesis of Very Long Chain Fatty Acids and Sphingolipids,” The Journal of Cell Biology, vol. 149, No. 3, May 1, 2000, pp. 707-717.
P. Tvrdik, et al., “Cig30, a Mouse Member of a Novel Membrane Protein Gene Family, Is Involved in the Recruitment of Brown Adipose Tissue,” The Journal of Biological Chemistry, vol. 272, No. 50, Dec. 12, 1997, pp. 31738-31746.
Genbank Accession No. AF170907, May. 30, 2000.
Genbank Accession No. AI343530, Dec. 30, 1998.
Genbank Accession No. AL034374, Mar. 4, 2003.
Genbank Accession No. AF231981, Nov. 10, 2000.
Genbank Accession No. AAF70631, Nov. 10, 2000.
Genbank Accession No. AA282346, Apr. 3, 1997.
Genbank Accession No. BE779576, Sep. 18, 2000.
Genbank Accession No. BAA91096, Sep. 13, 2003.
Genbank Accession No. AK000341, Sep. 13, 2003.
Genbank Accession No. AI815960, Jul. 9, 1999.
Genbank Accession No. BE778035, Sep. 18, 2000.
Genbank Accession No. CAB70777, Feb. 18, 2000.
Genbank Accession No. AK027216, Sep. 29, 2000.
Genbank Accession No. AK027031, Sep. 12, 2003.
Genbank Accession No. BAB15632, Sep. 12, 2003.
Genbank Accession No. AL160091, Mar. 10, 2000.
Genbank Accession No. U97107, Mar. 19, 1998.
Genbank Accession No. AF292387, Nov. 2, 2000.
Genbank Accession No. AL132875, Dec. 21, 2000.
Genbank Accession No. AL137506, Jan. 27, 2000.
Genbank Accession No. AK027216, Sep. 12, 2003.
Genbank Accession No. BE878648, Sep. 26, 2003.
Genbank Accession No. AF151846, Jun. 1, 1999.
Genbank Accession No. AY037298, Jul. 4, 2001.
Allen Stephen John
De Antueno Roberto Justo
Goldberg Y. Paul
Haardt Martin
Jenkins D. Kenneth
Howrey LLP
Saidha Tekchand
Xenon Pharmaceuticals Inc.
LandOfFree
Human elongase genes and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human elongase genes and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human elongase genes and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3808233